Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

New alopecia treatments aim for better results and fewer side effects.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Damaging mitochondrial DNA in mice speeds up aging due to increased reactive oxygen species, not through the p53/p21 pathway.

Mutations in the KRT85 gene cause hair and nail problems.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Type I interferons play a key role in the development of various skin diseases.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.